SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000899140-22-000338
Filing Date
2022-02-14
Accepted
2022-02-14 16:46:28
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.POINT72 HONG KONG LTDSTEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 1) g020822a.htm SC 13G/A 62615
2 JOINT FILING AGREEMENT g020822b.htm EX-99.1 2989
  Complete submission text file 0000899140-22-000338.txt   67243
Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

IRS No.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Subject) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88976 | Film No.: 22633655
SIC: 2834 Pharmaceutical Preparations